Darbs Vivos Oftalmoloģiskās ķirurģijas sistēma, kura autors ir Olcayto Guelec and David Geuder, ir augsti novērtēts un ļoti prestižās 2026 Zelta balva A' Design Award ieguvējs kategorijā Medicīnas ierīču un medicīnas aprīkojuma dizains.
ZeltaMedicīnas produkts· 2026
Vivos Oftalmoloģiskās ķirurģijas sistēma
Autors: Olcayto Guelec and David Geuder
Klients: Geuder AG
Zelta balva A' Design Award ieguvējs kategorijā Medicīnas produkts
Verificēts balvas ieguvējs
Verificēt balvas statusu dizainam #182492Dizains
Par Vivos Oftalmoloģiskās ķirurģijas sistēma
Vivos no jauna definē ķirurģisko darba staciju kā platformu, kas attīstās līdztekus klīniskajām ambīcijām. Trīs konfigurācijas — Core, Nova un Nova+ — paplašina iespējas bez sistēmas nomaiņas, kas ir vienīgā šāda veida jaunināšanas arhitektūra oftalmoloģiskajā ķirurģijā. Vienota saskarne, kuras pirmās lietošanas apmierinātība bez iepriekšējas apmācības apstiprināta 91,7 procentu līmenī, atspoguļo dizainu, kas veidots ap ķirurgu, nevis ap procedūru. Izgaismoti instrumentu savienojumi, izsmalcināti materiāli un savaldīgs detalizējums piešķir ierīcei mierīgu un pārliecinātu klātbūtni, brīvu no šai kategorijai raksturīgā vizuālā trokšņa.
Atzinība
Par Zelta balva A' Design Award
Vivos Oftalmoloģiskās ķirurģijas sistēma ir Zelta balvas A' Design Award ieguvējs, ārkārtīgi prestiža atzinība, ko piešķir pirmšķirīgiem, brīnišķīgiem un izciliem dizainiem. Zelta ieguvēji ir ļoti inovatīvi, tālredzīgi un žilbinoši spoži darbi, kas atspoguļo to dizaineru talantu, gudrību un meistarību. Sagaidāms, ka Vivos Oftalmoloģiskās ķirurģijas sistēma būs ļoti slavēts, tendenci veidojošs un monumentāls izgudrojums, kas sniedz nebijušu vērtību. Šis ar Zelta balvu apbalvotais dizains ir lielisks, cienīts projekts, kas paplašina mākslas, zinātnes, dizaina un tehnoloģiju robežas. Vivos Oftalmoloģiskās ķirurģijas sistēma izraisa intensīvu vēlmi, modina kaislību, veicina radošumu un valdzina.
Aiz dizaina
Preses materiāli
Dizainera sniegtie autori, komandas dalībnieki un tehniskie dati.
- Unikālās īpašības
- Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
- Izmēri un iepakojums
- Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
- Birkas
- Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
- Ražošanas tehnoloģija
- Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
- Dizaina izaicinājums
- The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
- Pētījums
- Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
- Iedvesma
- Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
- Projekta ilgums
- The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
- Darbības plūsma
- Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
- Patenti
- Design copyright: Geuder AG, 2026. Patent application pending. All rights reserved.
- Komandas dalībnieki
- Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
- Attēlu autori
- Photography Geuder AG, 2026
Sponsorēts
Izpētiet ārpus Designers.org
Atklājiet produktus, pakalpojumus un iespējas no mūsu reklāmas partneriem.
Atklājiet vairāk
Saistītie dizaini
Iepazīstiet citus apbalvotos dizainus no tās pašas kategorijas, atlasītus pēc nopelniem.